UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19

Scientific reports, 2021-01, Vol.11 (1), p.1-12, Article 1930

2021

Volltextzugriff (PDF)

Cognitive deficits and associated neurological complications in individuals with Down's syndrome

Lancet neurology, 2010-06, Vol.9 (6), p.623-633

2010

Volltextzugriff (PDF)

Meta-analysis of transcriptomic data reveals clusters of consistently deregulated gene and disease ontologies in Down syndrome

PLoS computational biology, 2021-09, Vol.17 (9), p.e1009317-e1009317

2021

Volltextzugriff (PDF)

A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction

Nature communications, 2020-02, Vol.11 (1), p.782-782, Article 782

2020

Volltextzugriff (PDF)

Top ten discoveries of the year: Neurodevelopmental disorders

Free Neuropathology, 2020-01, Vol.1

Dierssen, Mara

2020

Volltextzugriff (PDF)

Modeling the impact of neuromorphological alterations in Down syndrome on fast neural oscillations

PLoS computational biology, 2024-07, Vol.20 (7), p.e1012259

2024

Volltextzugriff (PDF)

Editorial: Brain Insulin Resistance in Neurodevelopmental and Neurodegenerative Disorders: Mind the Gap

Frontiers in neuroscience, 2021-08, Vol.15, p.730378-730378

2021

Volltextzugriff (PDF)

Down syndrome: the brain in trisomic mode

Nature reviews. Neuroscience, 2012-12, Vol.13 (12), p.844-858

Dierssen, Mara

2012

Volltextzugriff (PDF)

Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions

Frontiers in neuroscience, 2020-07, Vol.14, p.670-670

2020

Volltextzugriff (PDF)

Rethinking Intellectual Disability from Neuro- to Astro-Pathology

International journal of molecular sciences, 2020-11, Vol.21 (23), p.9039

2020

Volltextzugriff (PDF)

Potential role of olive oil phenolic compounds in the prevention of neurodegenerative diseases

Molecules, 2015-03, Vol.20 (3), p.4655-4680

2015

Volltextzugriff (PDF)

Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice

Proceedings of the National Academy of Sciences - PNAS, 2012-11, Vol.109 (45), p.E3136-E3145

2012

Volltextzugriff (PDF)

Beyond Quiescent and Active: Intermediate Microglial Transcriptomic States in a Mouse Model of Down Syndrome

International journal of molecular sciences, 2024-03, Vol.25 (6), p.3289

2024

Volltextzugriff (PDF)

Fluorescent transgenic mouse models for whole-brain imaging in health and disease

Frontiers in molecular neuroscience, 2022-09, Vol.15, p.958222

2022

Volltextzugriff (PDF)

Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome

Scientific reports, 2021-02, Vol.11 (1), p.4715-13, Article 4715

2021

Volltextzugriff (PDF)

Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease

Current drug targets, 2017-02, Vol.18 (2), p.174-195

2017

Volltextzugriff (PDF)

Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A

Neurobiology of disease, 2013-12, Vol.60, p.18-31

2013

Volltextzugriff (PDF)

Aneuploidy: From a Physiological Mechanism of Variance to Down Syndrome

Physiological reviews, 2009-07, Vol.89 (3), p.887-920

2009

Volltextzugriff (PDF)

Targeting the endocannabinoid system in the treatment of fragile X syndrome

Nature medicine, 2013-05, Vol.19 (5), p.603-607

2013

Volltextzugriff (PDF)

Specific Susceptibility to COVID-19 in Adults with Down Syndrome

Neuromolecular medicine, 2021-12, Vol.23 (4), p.561-571

2021

Volltextzugriff (PDF)

Effect of epigallocatechin gallate on the body composition and lipid profile of down syndrome individuals: Implications for clinical management

Clinical nutrition (Edinburgh, Scotland), 2020-04, Vol.39 (4), p.1292-1300

2020

Volltextzugriff (PDF)

Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans

Molecular nutrition & food research, 2014-02, Vol.58 (2), p.278-288

2014

Volltextzugriff (PDF)

Social Factors Influence Behavior in the Novel Object Recognition Task in a Mouse Model of Down Syndrome

Frontiers in behavioral neuroscience, 2021-11, Vol.15, p.772734-772734

2021

Volltextzugriff (PDF)

From neural to genetic substrates of panic disorder: Insights from human and mouse studies

European journal of pharmacology, 2015-07, Vol.759, p.127-141

2015

Volltextzugriff (PDF)

1 – 25 von 243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(216)

Publikationsform

Artikel
(235)
Bücher
(3)
Texte
(3)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19

Cognitive deficits and associated neurological complications in individuals with Down's syndrome

Meta-analysis of transcriptomic data reveals clusters of consistently deregulated gene and disease ontologies in Down syndrome

A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction

Top ten discoveries of the year: Neurodevelopmental disorders

Modeling the impact of neuromorphological alterations in Down syndrome on fast neural oscillations

Editorial: Brain Insulin Resistance in Neurodevelopmental and Neurodegenerative Disorders: Mind the Gap

Down syndrome: the brain in trisomic mode

Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions

Rethinking Intellectual Disability from Neuro- to Astro-Pathology

Potential role of olive oil phenolic compounds in the prevention of neurodegenerative diseases

Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial

Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice

Beyond Quiescent and Active: Intermediate Microglial Transcriptomic States in a Mouse Model of Down Syndrome

Fluorescent transgenic mouse models for whole-brain imaging in health and disease

Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome

Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease

Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A

Aneuploidy: From a Physiological Mechanism of Variance to Down Syndrome

Targeting the endocannabinoid system in the treatment of fragile X syndrome

Specific Susceptibility to COVID-19 in Adults with Down Syndrome

Effect of epigallocatechin gallate on the body composition and lipid profile of down syndrome individuals: Implications for clinical management

Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans

Social Factors Influence Behavior in the Novel Object Recognition Task in a Mouse Model of Down Syndrome

From neural to genetic substrates of panic disorder: Insights from human and mouse studies

Suchergebnisse filtern